|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Number of the document | 2787978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12813099.4 |
| Date of filing the European patent application | 2012-12-07 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/002681 |
| Date | 2012-12-07 |
| (87) | Number | WO 2013/084059 |
| Date | 2013-06-13 |
| (30) | Number | Date | Country code |
| 201161569193 P | 2011-12-09 | US |
| (72) |
MULEY, Sheetal, US
|
| (73) |
Purdue Pharma LP,
One Stamford Forum 201 Tresser Boulevard, Stamford, CT 06901-3431,
US
|
| (54) | PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE |
| PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE |